Trinity Biotech TRIB will release its quarterly earnings report on Friday, 2024-11-15. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Trinity Biotech to report an earnings per share (EPS) of $-0.54.
The market awaits Trinity Biotech's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Here's a look at Trinity Biotech's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.60 | -0.75 | ||
| EPS Actual | -0.71 | -0.37 | -0.72 | -0.88 |
| Price Change % | -9.0% | 4.0% | -1.0% | -4.0% |
Performance of Trinity Biotech Shares
Shares of Trinity Biotech were trading at $1.55 as of November 12. Over the last 52-week period, shares are down 18.95%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Trinity Biotech visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
